Samjin’s anti-dementia drug targeting sales of 10 billion won this year

Samjin Pharmaceutical said Thursday that the sales of its anti-dementia drug Neutoin (donepezil) will reach 10 billion won this year on growing demand due to the growing number of dementia patients triggered by fueled by the rapid aging of the country's population.

Neutoin, which is already on the market in pill form, is used to treat mild to moderate dementia caused by Alzheimer's disease. ...